Explore how Tocilizumab, an IL-6 receptor inhibitor, is revolutionizing rheumatoid arthritis treatment through targeted therapy and proven clinical efficacy.
Exploring the complex relationship between tocilizumab treatment and antimicrobial prescribing patterns during the COVID-19 pandemic